The microcirculation in venous hypertension

Cardiovascular Research

Volumn 32, Issue 4, 1996, Pages 789-795

  Smith, P D Coleridge ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Hypertension, venous; Microcirculation; Neutrophils; Ulceration; Varicose, vein

Indexed keywords

CD11B ANTIGEN; LACTOFERRIN; LEUKOCYTE ELASTASE;

CHRONIC VEIN INSUFFICIENCY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYPERTENSION; MICROCIRCULATION; NORMAL HUMAN; PRIORITY JOURNAL; REVIEW; SKIN ULCER;

EID: 0030271194     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(96)00147-2     Document Type: Review

References (59)

1. [1] Callam MJ, Ruckley CV, Harper DR, Dale JJ. Chronic ulceration of the leg: extent of the problem and provision of care. Br Med J 1985;290:1855-1856.
2. [2] Bosanquet N. Costs of venous ulcers: from maintenance therapy to investment programmes. Phlebology 1992;Suppl 1:44-46.
3. [3] Killewich LA, Martin R, Cramer M, Beach KW, Strandness DE. An objective assessment of the physiologic changes in the post-thrombotic syndrome. Arch Surg 1985;120:424-426.
4. [4] Nicolaides AN, Zukowski A, Lewis R, Kyprianou P, Malouf GM. Venous pressure measurements in venous problems. In: Bergan JJ, Yao JST, eds. Surgery of the Veins. Orlando, FL: Grune and Stratton Inc., 1985:111-118.
5. [5] Browse NL, Burnand KG. The cause of venous ulceration. Lancet 1982;ii:243-245.
6. [6] Stacey MC, Burnand KG, Layer GT, Pattison M. Transcutaneous oxygen tensions as a prognostic indicator and measure of treatment of recurrent ulceration. Br J Surg 1987;74:545.
7. [7] Clyne CAC, Ramsden WH, Chant ADB, Wenster JHH. Oxygen tension in the skin of the gaiter area of limbs with venous ulceration. Br J Surg 1985;72:644-647.
8. [8] Moosa HH, Falanga V, Steed-DL, et al. Oxygen diffusion in chronic venous ulceration. J Cardiovasc Surg Torino 1987;28:464-467.
9. [9] Cheatle TR, Stibe ECL, Shami SK, Scurr JH, Coleridge Smith PD. Vasodilatory capacity of the skin in venous disease and its relationship to transcutaneous oxygen tension. Br J Surg 1990;78:607-610.
10. [10] Cheatle TR, McMullin GM, Farrah J, Coleridge Smith PD, Scurr JH. Three tests of microcirculatory function in the evaluation of treatment for chronic venous insufficiency. Phlebology 1990;5:165-172.
11. [11] Stibe E, Cheatle TR, Coleridge Smith PD, Scurr JH. Liposclerotic skin: a diffusion block or a perfusion problem? Phlebology 1990;5:231-236.
12. [12] Michel CC. Oxygen diffusion in oedematous tissue and through pericapillary cuffs. Phlebology 1990;5:223-230.
13. [13] Nemeth AJ, Falanga V, Alstadt SP, Eaglstein WH. Ulcerated edematous limbs: effect of edema removal on transcutaneous oxygen measurements. J Am Acad Dermatol 1989;20:191-197.
14. [14] Schmeller W, Roszinski S, Tronnier M, Gmelin E. Combined morphological and physiological examinations in lipodermatosclerosis. In: Raymond-Martimbeau, Prescott R, Zummo M, eds. Phlebologie '92. Paris: John Libbey Eurotext Ltd, 1992:172-174.
15. [15] Moyses C, Cederholm-Williams SA, Michel CC. Haemoconcentration and the accumulation of white cells in the feet during venous stasis. Int J Microcirc Clin Exp 1987;5:311-320.
16. [16] Thomas PRS, Nash GB, Dormandy JA. White cell accumulation in the dependent legs of patients with ambulatory venous hypertension: a possible mechanism for trophic changes in the skin. Br Med J 1988;296:1693-1695.
17. [17] Vanscheidt W, Kresse O, Hach-Wunderle V, et al. Leg ulcer patients: no decreased fibrinolytic response but white cell trapping after venous occlusion of the upper limb. Phlebology 1992;7:92-96.
18. [18] Coleridge Smith PD, Thomas P, Scurr JH, Dormandy JA. Causes of venous ulceration: a new hypothesis. Br Med J 1988;296:1726-1728.
19. [19] Schmid-Schoenbein GW, Fung YC, Zweifach BW. Vascular endothelium-leukocyte interaction; sticking shear force in venules. Circ Res. 1975;36:173-184.
20. [20] Shields DA, Andaz S, Abeysinghe RD, Porter JB, Scurr JH, Coleridge Smith PD. Neutrophil activation in experimental ambulatory venous hypertension. Phlebology 1994;9:119-124.
21. [21] Shields D, Andaz SK, Timothy-Antoine CA, Scurr JH, Porter JB. CD11b/CD18 as a marker of neutrophil adhesion in experimental ambulatory venous hypertension. Phlebology 1995;Suppl 1:108-109.
22. [22] Shields DA, Andaz S, Abeysinghe RD, Porter JB, Scurr JH, Coleridge Smith PD. Plasma lactoferrin as a marker of white cell degranulation in venous disease. Phlebology 1994;9:55-58.
23. [23] Shields DA, Andaz SK, Sarin S, Scurr JH, Coleridge Smith PD. Plasma elastase in venous disease. Br J Surg 1994;81:1496-1499.
24. [24] Shields D, Saharay M, Timothy-Antoine CA, Porter JB, Scurr JH. Neutrophil CD11b expression in patients with venous disease. Phlebology 1995;Suppl 1:108-109.
25. [25] Burnand KG, Whimster I, Naidoo A, Browse NL. Pericapillary fibrin in the ulcer-bearing skin of the leg: the cause of lipodermatosclerosis and venous ulceration. Br Med J 1982;285:1071-1072.
26. [26] Haselbach P, Vollenweider U, Moneta G, Bollinger A. Microangiopathy in severe chronic venous insufficiency evaluated by fluorescence video-microscopy. Phlebology 1986;1:159-169.
27. [27] Wilkinson LS, Bunker C, Edwards JC, Scurr JH, Coleridge Smith PD. Leukocytes: their role in the etiopathogenesis of skin damage in venous disease. J Vasc Surg 1993;17:669-675.
28. [28] Veraart JC, Verhaegh ME, Neumann HA, Hulsmans RF, Arends JW. Adhesion molecule expression in venous leg ulcers. Vasa 1993;22:213-218.
29. [29] Herrick SE, Sloan P, McGurk M, Freak L, McCollum CN, Ferguson MW. Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers. Am J Pathol 1992 141:1085-1095.
30. [30] Scott HJ, McMullin GM, Coleridge Smith PD, Scurr JH. A histological study into white blood cells and their association with lipodermatosclerosis and ulceration. Br J Surg 1990;78:210-211.
31. [31] Falanga V, Kruskal J, Franks JJ. Fibrin-and fibrinogen-related antigens in patients with venous disease and venous ulceration. Arch Dermatol 1991;127:75-78.
32. [32] Franzeck UK, Speiser D, Haselbach P, Bollinger A. Morphologic and dynamic microvascular abnormalities in chronic venous incompetence (CVI). In: Davy A, Stemmer R, eds. Phlebologie 1989. Montrouge, France: John Libbey Eurotext Ltd, 1989:104-107.
33. [33] Adams EF. The Genuine Works of Hippocrates. London: Sydenham Press, 1849.
34. [34] Wiseman R. Several Chirurgical Treatises. London: Royston and Took, 1676.
35. [35] Vandongen YK, Rashid P, Stacey MC. The effectiveness of compression stockings in reducing lipodermatosclerosis. Phlebology 1995;Suppl 1:862-864.
36. [36] Stacey MC, Vandongen Y, Trengove N, Hoskin S, Thompson P, Pearce C. The effectiveness of compression in healing venous ulcers. Phlebology 1995;Suppl 1:929-931.
37. [37] Cornwall JV, Doré C, Lewis JD. To graduate or not? The effect of compression garments on venous refilling time. In: Negus D. Jantet G, eds. Phlebology 85. London: Libbey, 1986.
38. [38] Horner J, Fernandes E, Fernandes J, Nicolaides AN. Value of graduated compression stockings in deep venous insufficiency. Br Med J 1980;280:820.
39. [39] Jones NAG, Webb PJ, Rees RI, Kakkar VV. A physiological study of elastic compression stockings in venous disorders of the leg. Br J Surg 1980 67:569-572.
40. [40] Partsch H, Do we need firm compression stockings exerting high pressure? Vasa 1984;13:52.
41. [41] Abu-Own A, Shami SK, Chittenden SJ, Farrah J, Scurr JH, Coleridge Smith PD. Microangiopathy of the skin and the effect of leg compression in patients with chronic venous insufficiency. J Vasc Surg 1993 17:429-430.
42. [42] Balmer A, Limoni C. A double-blind placebo-controlled trial of VENORUTON on the symptoms and signs of chronic venous insufficiency. Vasa 1980;9:76-82.
43. [43] Pulvertaft TB. General practice treatment of symptoms of venous insufficiency with oxerutins. Results of a 660 patient multicentre study in the UK. Vasa 1983;12:373-376.
44. [44] Bergqvist D, Hallboeok T, Lindblad B, Lindhagen A. A double-blind trial of O-(β-hydroxyethyl)-rutosides in patients with chronic venous insufficiency. Vasa 1981;10:253-260.
45. [45] Neumann HAM, van den Broek MJTB. Evaluation of O-(β-hydroxyethyl)-rutosides in chronic venous insufficiency by means of non-invasive techniques. Phlebology 1990;5(Suppl 1):13-20.
46. [46] de Jongste AB, Jonker JJC, Huisman MV, ten Cate JW, Azar AJ. A double-blind trial on the short-term efficacy of HR in patients with the post-thrombotic syndrome. Phlebology 1990;5(Suppl 1):21-22.
47. [47] Nocker W, Diebschlag W, Lehmacher W. Clinical trials of the dose-related effects of O-(β-hydroxyethyl)-rutosides in patients with chronic venous insufficiency. Phlebology 1990;5(Suppl 1):23-26.
48. [48] Pulvertaft TB. Paroven in the treatment of chronic venous insufficiency. Practitioner 1979;223:838-841.
49. [49] Wright DD, Franks PJ, Blair SD, Backhouse CM, Moffatt C, McCollum CN. Oxerutins in the prevention of recurrence in chronic venous ulceration: randomised controlled trial. Br J Surg 1991;78:1269-1270.
50. [50] Friesenecker B, Tsai AG, Intaglietta M. Cellular basis of inflammation, oedema and the activity of Daflon 500 mg. Int J Microcirc 1995;15:17-21.
51. [51] Dereure O, Guilhou JJ, Marzin L, et al. Leg ulcer healing with Daflon 500 mg treatment. Phlebology 1995;Suppl 1:1113-1115.
52. [52] Browse NL, Gray L, Jarrett PEM, Morland M. Blood and vein-wall fibrinolytic activity in health and vascular disease. Br Med J 1977;1:478-481.
53. [53] Leach RD. Venous ulceration, fibrinogen and fibrinolysis, Ann R Coll Surg Engl 1984;66:258-263.
54. [54] Wolfe JHN, Morland M, Browse NL. The fibrinolytic activity of varicose veins. Br J Surg 1979;66:185-187.
55. [55] Layer GT, Stacey MC, Burnand KG. Stanozolol and the treatment of venous ulceration - an interim report. Phlebology 1986;1:197-203.
56. [56] McMuilin GM, Watkin GT, Coleridge Smith PD, Scurr JH. Efficacy of fibrinolytic enhancement in the treatment of venous insufficiency. Phlebology 1991;6:233-239.
57. [57] Rudovsky G. Intravenous prostaglandin E1 in the treatment of venous ulcers - a double-blind, placebo-controlled trial. Vasa 1989;Suppl 28:39-43.
58. [58] Colgan M-P, Dormandy JA, Jones PW, Schraibman IG, Shanik DG. Oxpentifylline treatment of venous ulcers of the leg. Br Med J 1990;300:972-975.
59. [59] Dale JJ, Ruckley CV, Harper DR, Gibson B, Nelson EA, Prescott RJ. A randomised double-blind placebo controlled trial of oxpentifylline in the treatment of venous leg ulcers. Phlebology 1995;Suppl 1:917-918.